Medeon Biodesign, Inc. (TPEX:6499)
Taiwan · Delayed Price · Currency is TWD 61.70
-0.20 (-0.32%)
Aug 19, 2026, 9:41 AM CST
Medeon Biodesign Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 428.07 | 419.43 | 292.81 | 196.26 | 298.32 | 68.96 |
Revenue Growth | 8.54% | 43.24% | 49.19% | -34.21% | 332.61% | -43.96% |
Gross Profit Gross Profit Growth | 56.08 | 58.83 | 83.41 | 14.38 | 186.81 | 28.63 |
Operating Income Operating Income Growth | -619.52 | -722.51 | -885.61 | -839.57 | -487.84 | -495.59 |
Net Income Net Income Growth | -558.53 | -668.06 | -805.51 | -1,205 | -433.76 | 2,078 |
Earnings Per Share EPS Growth | -5.90 | -7.24 | -8.74 | -13.09 | -4.71 | 22.65 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Parts Sales Department Medical Parts Sales Department Growth | 431.84 | 419.43 | 253.47 | 185.56 | 88.78 | - |
Development Department Development Department Growth | - | - | 39.34 | 10.7 | 209.54 | 68.96 |
Total Total Growth | 431.84 | 419.43 | 292.81 | 196.26 | 298.32 | 68.96 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 959.51 | 1,220 | 1,207 | 2,142 | 1,547 | 2,350 |
Total Debt Total Debt Growth | 151.49 | 113.05 | 168.4 | 186.74 | 198.91 | 30.24 |
Net Cash (Debt) Net Cash Growth | 808.02 | 1,107 | 1,039 | 1,955 | 1,348 | 2,320 |
Net Cash Growth | 22.09% | 6.55% | -46.87% | 45.01% | -41.87% | 36.98% |
Net Cash Per Share Net Cash Per Share Growth | 8.53 | 11.99 | 11.27 | 21.24 | 14.65 | 25.19 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -511.78 | -629.14 | -832.67 | -755.08 | -461.34 | -293.38 |
Capital Expenditures CapEx Growth | -9.1 | -16.47 | -74.3 | -55.29 | -140.57 | -8.32 |
Free Cash Flow Free Cash Flow Growth | -520.89 | -645.61 | -906.97 | -810.36 | -601.91 | -301.69 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 13.10% | 14.03% | 28.49% | 7.32% | 62.62% | 41.52% |
Operating Margin | -144.72% | -172.26% | -302.45% | -427.78% | -163.53% | -718.69% |
Pretax Margin | -143.55% | -171.59% | -293.24% | -627.06% | -147.20% | -745.26% |
Profit Margin | -130.48% | -159.28% | -275.10% | -613.78% | -145.40% | 3013.75% |
FCF Margin | -121.68% | -153.93% | -309.75% | -412.90% | -201.77% | -437.51% |
| Fiscal Year | FY 2022 | FY 2021 |
|---|---|---|
| Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.476 | 0.794 |
Dividend Per Share Growth | -40.00% | - |
Dividend Yield | 0.88% | 1.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 3.17 |
Forward PE | - | 16.78 | 16.78 | 16.78 | 16.78 | 49.52 |
PS Ratio | 14.02 | 20.78 | 12.48 | 21.88 | 17.07 | 95.60 |